Compare RDVT & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDVT | INMD |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.2M | 842.0M |
| IPO Year | 2017 | 2018 |
| Metric | RDVT | INMD |
|---|---|---|
| Price | $69.28 | $14.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $62.00 | $17.33 |
| AVG Volume (30 Days) | 160.0K | ★ 773.2K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.00 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $90,252,000.00 | N/A |
| Revenue This Year | $16.31 | $1.74 |
| Revenue Next Year | $13.83 | $3.26 |
| P/E Ratio | $218.40 | ★ $10.11 |
| Revenue Growth | ★ 20.03 | N/A |
| 52 Week Low | $33.40 | $12.72 |
| 52 Week High | $67.68 | $16.74 |
| Indicator | RDVT | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 82.15 | 66.50 |
| Support Level | $50.66 | $14.58 |
| Resistance Level | N/A | $15.23 |
| Average True Range (ATR) | 2.66 | 0.28 |
| MACD | 0.97 | 0.13 |
| Stochastic Oscillator | 96.04 | 79.80 |
Red Violet Inc builds proprietary technologies and applies analytical capabilities to deliver identity intelligence. The company's solutions enable the real-time identification and location of people, businesses, assets, and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Its cloud-native, AI-enabled identity intelligence platform, CORE, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. The company generates substantially all of its revenue from licensing its solutions.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.